Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1685675

registered interest
date	29/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to prevent NHS drug shortages.
tabling member printed	Lord Bourne of Aberystwyth
uin	HL1978
answer	answer is ministerial correction date of answer 06/02/2024 answer text <p>There are around 14,000 licensed medicines and the overwhelming majority are in good supply. However, the medicine supply chain is highly regulated, complex, and global, meaning there can sometimes be supply issues which affect the United Kingdom, along with other countries around the world.</p><p>Medicine supply problems can occur for several reasons such as manufacturing difficulties, regulatory non-compliance, access to raw materials, sudden demand spikes or distribution issues.</p><p>While it’s not always possible to prevent supply issues from occurring, there is a team within the Department that has a range of well-established tools and processes to manage them when they arise, working closely with the pharmaceutical industry, the National Health Service, the Medicines and Healthcare products Regulatory Agency and others operating in the supply chain to help mitigate the risks to patients.</p> answering member printed Lord Markham question first answered 06/02/2024 14:24:10 answering member 4948 label Biography information for Lord Markham
tabling member	4282 label Biography information for Lord Bourne of Aberystwyth

1681692

registered interest
date	11/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Fourth Report of the House of Lords Public Services Committee, Session 2022-23, entitled Homecare medicines services: an opportunity lost, HL Paper 269, what his position is in respect of the recommendation that following the interim findings of the NHS England review, and by no later than April 2024, the Government should establish and fund an independent review into the homecare system.
tabling member constituency	Kingston upon Hull West and Hessle
tabling member printed	Emma Hardy
uin	9280
answer	answer is ministerial correction date of answer 16/01/2024 answer text <p>We are carefully considering all the conclusions and recommendations made in the report and will respond to the Committee shortly.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/01/2024 17:36:20 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4645 label Biography information for Emma Hardy

1680502

registered interest
date	08/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has made a recent assessment of the potential merits of reconstituting her Department's Medicines Supply Team.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	8487
answer	answer is ministerial correction date of answer 15/01/2024 answer text <p>The Department’s medicines supply team has well-established procedures to deal with medicine shortages, whatever the cause, and works closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England and others operating in the supply chain to help prevent shortages and to ensure that the risks to patients are minimised when shortages do arise.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 15/01/2024 15:33:23 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1680557

registered interest
date	08/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress she has made on establishing a Falsified Medicines scheme.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	8581
answer	answer is ministerial correction date of answer 11/01/2024 answer text <p>The Medicines &amp; Medical Devices Act 2021 included provisions that enable the introduction and use of a falsified medicines system in the United Kingdom. The Department is considering the right approach for the future, and regulations would be needed to set out the detail of any scheme, which would require consultation.</p><p>The Medicines and Healthcare products Regulatory Agency has robust measures in place for the management of falsified medicines detected by the UK supply chain.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 11/01/2024 18:34:36 answering member 4044 label Biography information for Andrew Stephenson previous answer version 10519 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	4769 label Biography information for Daisy Cooper

1678742

registered interest
date	18/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to ensure that rheumatology teams involved in homecare medicines services are consulted about possible changes to the delivery, monitoring and standards that define homecare medicines services made as part of NHS England’s desktop review.
tabling member printed	Lord Shinkwin
uin	HL1298
answer	answer is ministerial correction date of answer 27/12/2023 answer text <p>Homecare medicines are used by a wide range of clinical services and patients. NHS England has been carrying out an internal review of homecare medicines services to understand the issues affecting these groups in more detail. Representatives from the rheumatology sector have been involved in this work.</p><p>The next steps are to bring together data from this review with the House of Lords inquiry report recommendations to shape a programme of work on homecare medicines. Engagement with relevant key stakeholders will continue throughout this process.</p><p>The Department is carefully considering all the conclusions and recommendations made in the report and will respond to the House of Lords Public Services Committee in January 2024.</p> answering member printed Lord Markham question first answered 27/12/2023 13:07:51 answering member 4948 label Biography information for Lord Markham
tabling member	4557 label Biography information for Lord Shinkwin

1678743

registered interest
date	18/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what discussions they have had with NHS England about its desktop review of homecare medicines services, and whether they will publish its terms of reference and timetable.
tabling member printed	Lord Shinkwin
uin	HL1299
answer	answer is ministerial correction date of answer 27/12/2023 answer text <p>NHS England’s desktop exercise to review homecare medicines services is not guided by terms of reference. The next steps are to bring together data from the desktop exercise with the House of Lords inquiry report recommendations to shape a programme of work on homecare medicines. The Public Services Committee will be updated on progress in January and March 2024.</p> answering member printed Lord Markham question first answered 27/12/2023 13:08:24 answering member 4948 label Biography information for Lord Markham
tabling member	4557 label Biography information for Lord Shinkwin

1678745

registered interest
date	18/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the impact of delays, workforce shortages, and lack of e-prescribing systems, on the health and well-being of patients receiving homecare medicines services.
tabling member printed	Lord Shinkwin
uin	HL1301
answer	answer is ministerial correction date of answer 27/12/2023 answer text <p>NHS England has been carrying out a desktop exercise to review homecare medicines services. The next steps are to bring together data from the internal review with the House of Lords inquiry report recommendations to shape a programme of work on homecare medicines. The Department is carefully considering all the conclusions and recommendations made in the report and will respond in due course.</p><p>The House of Lords Public Services Committee will be updated in January 2024.</p> answering member printed Lord Markham question first answered 27/12/2023 13:08:08 answering member 4948 label Biography information for Lord Markham
tabling member	4557 label Biography information for Lord Shinkwin

1678746

registered interest
date	18/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they intend to publish (1) national-level, and (2) NHS trust-level, key performance indicators on missed doses and delayed treatment initiation to monitor the performance and safety of homecare medicines services.
tabling member printed	Lord Shinkwin
uin	HL1302
answer	answer is ministerial correction date of answer 27/12/2023 answer text <p>NHS England is committed to improving patient safety and understanding the important role data can play in driving quality improvement.</p><p>There are currently national key performance metric definitions available as part of the Royal Pharmaceutical Society Homecare Services Professionals Standards which include definitions criteria on the number of failed deliveries, missed doses and patient safety incidents. Patients routinely hold approximately two weeks’ worth of supply of medicines to minimise the risk of a missed or delayed delivery becoming a missed dose.</p><p>NHS England has been carrying out an internal review on homecare medicines services. Extensive stakeholder engagement has been undertaken on revising the national key performance indicators (KPIs) and a transition to new KPIs will begin in spring 2024, with full reporting expected by autumn 2024.</p> answering member printed Lord Markham grouped question UIN HL1303 question first answered 27/12/2023 13:07:22 answering member 4948 label Biography information for Lord Markham
tabling member	4557 label Biography information for Lord Shinkwin

1678747

registered interest
date	18/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they have assessed the difference between a missed delivery and a missed dose of medicine in terms of their policy implications as part of the National Homecare Medicines Committee’s review of national homecare medicines services.
tabling member printed	Lord Shinkwin
uin	HL1303
answer	answer is ministerial correction date of answer 27/12/2023 answer text <p>NHS England is committed to improving patient safety and understanding the important role data can play in driving quality improvement.</p><p>There are currently national key performance metric definitions available as part of the Royal Pharmaceutical Society Homecare Services Professionals Standards which include definitions criteria on the number of failed deliveries, missed doses and patient safety incidents. Patients routinely hold approximately two weeks’ worth of supply of medicines to minimise the risk of a missed or delayed delivery becoming a missed dose.</p><p>NHS England has been carrying out an internal review on homecare medicines services. Extensive stakeholder engagement has been undertaken on revising the national key performance indicators (KPIs) and a transition to new KPIs will begin in spring 2024, with full reporting expected by autumn 2024.</p> answering member printed Lord Markham grouped question UIN HL1302 question first answered 27/12/2023 13:07:23 answering member 4948 label Biography information for Lord Markham
tabling member	4557 label Biography information for Lord Shinkwin

1678400

registered interest
date	15/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the implications for her Department's policies of the Public Services Committee report entitled Homecare Medicines Services: an opportunity lost, published on 16 November 2023.
tabling member constituency	Knowsley
tabling member printed	Sir George Howarth
uin	7158
answer	answer is ministerial correction date of answer 21/12/2023 answer text <p>NHS England has been carrying out a desktop exercise to review homecare medicines services. The next steps are to bring together data from the desktop exercise with the House of Lords inquiry report recommendations to shape a programme of work on homecare medicines. The Department is carefully considering all the conclusions and recommendations made in the report and will respond in due course.</p><p>The Department is required to publish a response to the report by 16 January 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 7159 question first answered 21/12/2023 13:03:42 answering member 4044 label Biography information for Andrew Stephenson
tabling member	481 label Biography information for Sir George Howarth